Skip to main content
Subscribe
Register
Sign in
Membership
Insights
Events
About
Subscribe
Register
Sign in
Stephen Taub
Latest Articles
Premium
Trian, ValueAct, Third Point Up Strongly in Good Year for Activists
Stephen Taub
October 8, 2013
Premium
Paulson Posts Double-Digit Year-to-Date Gains in Several Funds
Stephen Taub
October 7, 2013
Premium
Winton Up, Man Down in Mixed Month for CTAs
Stephen Taub
October 4, 2013
Premium
Third Point’s Daniel Loeb Trains Poison Pen on Sotheby’s
Stephen Taub
October 3, 2013
Premium
ValueAct Boosts Rockwell Collins Stake
Stephen Taub
October 1, 2013
Premium
Activism Pays Off for Jana, Mostly
Stephen Taub
October 1, 2013
Premium
David Einhorn’s Greenlight Capital Mostly Flat in September
Stephen Taub
October 1, 2013
Premium
Bigger Investors Do Better When It Comes to Hedge Fund Investing
Stephen Taub
September 27, 2013
Premium
The Reinvention of Thomas Sandell — As a Shareholder Activist
Stephen Taub
September 26, 2013
Premium
JOBS-Act Rule Proposal Could Have Big Impact on Managers
Stephen Taub
September 23, 2013
Premium
Caxton, Moore and Tudor Top the Macro Charts
Stephen Taub
September 17, 2013
Premium
Trian Partners’ Assets Top $7 Billion
Stephen Taub
September 12, 2013
Premium
Seth Klarman’s Baupost to Return Some Capital to Clients
Stephen Taub
September 11, 2013
Premium
Andrew Hall’s Astenbeck Surges in July and August
Stephen Taub
September 11, 2013
Premium
Citadel, Millennium Among Multistrat Managers Posting Gains in August
Stephen Taub
September 10, 2013
Premium
Einhorn's Greenlight Gains Despite Green Mountain Surge
Stephen Taub
September 3, 2013
Premium
Hedge Funds’ 21 Top Stock Picks
Stephen Taub
August 27, 2013
Premium
When Poison Pills Aren’t Poisonous
Stephen Taub
August 23, 2013
More Articles